Discovery of a Novel Cabazitaxel Nanoparticle-Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects using a β-Cyclodextrin-PEG Copolymer-Based Delivery Platform.
暂无分享，去创建一个
S. Eliasof | S. Svenson | S. Tripathi | D. Lazarus | Jungyeon Hwang | Derek G van der Poll | C. Metcalf | R. Cole | C. Teng | E. Rohde | B. Sweryda-Krawiec | P. Shum | Geeti Gangal | Donna Brown | R. Case | S. Kabir | Stephanie Harlfinger | D. G. van der Poll